23andMe FDA flap just a bump in the road say investors

Wall Street Journal | 
When the Food and Drug Administration told personal-genetics company 23andMe in November to stop sending consumers detailed information about their ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists